JWS
Juncture Wealth Strategies’s Catalyst Pharmaceutical CPRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.98M | Sell |
91,299
-4,825
| -5% | -$105K | 0.7% | 27 |
|
|
2025
Q1 | $2.33M | Sell |
96,124
-1,273
| -1% | -$30.9K | 0.91% | 20 |
|
|
2024
Q4 | $2.03M | Buy |
97,397
+160
| +0.2% | +$3.34K | 0.76% | 23 |
|
|
2024
Q3 | $1.93M | Buy |
97,237
+436
| +0.5% | +$8.67K | 0.75% | 22 |
|
|
2024
Q2 | $1.5M | Buy |
96,801
+2,218
| +2% | +$34.4K | 0.63% | 28 |
|
|
2024
Q1 | $1.51M | Buy |
94,583
+83,636
| +764% | +$1.33M | 0.65% | 28 |
|
|
2023
Q4 | $184K | Sell |
10,947
-140
| -1% | -$2.35K | 0.08% | 104 |
|
|
2023
Q3 | $130K | Sell |
11,087
-28,387
| -72% | -$332K | 0.06% | 113 |
|
|
2023
Q2 | $531K | Sell |
39,474
-908
| -2% | -$12.2K | 0.25% | 81 |
|
|
2023
Q1 | $670K | Buy |
+40,382
| New | +$670K | 0.33% | 58 |
|